ASCO Preview: Three Chinese Biotechs To Watch

 
• By Brian Yang and Dexter Jie Yan

BeiGene, Ascentage Pharma and I-Mab will be among the first Chinese pharma firms to report clinical trial results for their innovative drug candidates at this year’s ASCO meeting.

event preview
Scrip previews clinical data from three major Chinese biotechs at ASCO • Source: Shutterstock

More from China

More from Focus On Asia